Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC

Hepatocellular carcinoma (HCC) is one of the primary types of cancer that claims many lives worldwide, and its incidence continues to increase. Conventional therapies against liver cancer are inadequate, and the pathogenesis of HCC remains unclear. Thus, not only are more effective therapies to trea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Canadian Journal of Gastroenterology and Hepatology 2021, Vol.2021, p.5601678-9
Hauptverfasser:	Wei, Yulong, Song, Qingzhu, Zhang, Fenglan, Yuan, Tian
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biopsy Breast cancer Cancer therapies Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - genetics Cell Proliferation Chemotherapy Granulocyte Colony-Stimulating Factor Hepatitis B Hepatitis C Humans Hypoxia Kinases Liver cancer Liver Neoplasms - drug therapy Liver Neoplasms - genetics Lung cancer Medical prognosis Pathogenesis Patients Proteins Survival analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!